Analysis of Tim-3 as a therapeutic target in prostate cancer
Tim-3 (T-cell immunoglobulin domain and mucin domain–containing molecule 3) is a newly discovered immunomodulatory protein, which plays an important role in immunity regulation. Recent evidence suggests that Tim-3 is differentially regulated in a variety of tumors and has potential as a therapeutic...
Saved in:
| Main Authors: | Yongrui Piao, Xuanshun Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-07-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317716628 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression
by: Jialiu Luo, et al.
Published: (2024-12-01) -
Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party
by: Chenyu Lu, et al.
Published: (2024-03-01) -
LAG3, TIM3 and TIGIT: New Targets for Immunotherapy and Potential Associations with Radiotherapy
by: Camil Ciprian Mireștean, et al.
Published: (2025-04-01) -
HMGB1: A Promising Therapeutic Target for Prostate Cancer
by: Munirathinam Gnanasekar, et al.
Published: (2013-01-01) -
Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer
by: Qi Shen, et al.
Published: (2024-12-01)